Early versus late parenteral nutrition in term and late preterm infants: a randomised controlled trial.

Background: There is limited evidence regarding the optimal time to commence parenteral nutrition (PN) in term and late preterm infants.

Design: Single-centre, non-blinded, exploratory randomised controlled trial.

Setting: A level-3 neonatal unit in a stand-alone paediatric hospital.

Current parenteral nutrition practice and clinical outcomes of term and late preterm infants: A retrospective study.

Background And Aims: Limited studies have described parenteral nutrition (PN) practices and clinical outcomes in term and late preterm infants. The aim of this study was to describe the current practice of PN in term and late preterm infants and their short-term clinical outcomes.

Methods: We conducted a retrospective study in a tertiary NICU between October 2018 and September 2019.

Oral agents for acute severe hypertension in children with minimal or no symptoms.

Acute hypertension is common among children admitted to hospital, and large or rapid increases in blood pressure place children at risk of complications such as posterior reversible encephalopathy syndrome. Guidelines in the United States and Europe now include definitions guiding the identification of acute severe hypertension (otherwise known as hypertensive crisis) and its management. This review discusses these recommendations and the appropriate use of oral antihypertensive agents for children with minimal or no symptoms.

Early versus late parenteral nutrition in term and late preterm infants: study protocol for a randomised controlled trial.

Background: Despite the wide use of parenteral nutrition (PN) in neonatal intensive care units (NICU), there is limited evidence regarding the optimal time to commence PN in term and late preterm infants. The recommendations from the recently published ESPGHAN/ESPEN/ESPR/CPEN and NICE guidelines are substantially different in this area, and surveys have reported variations in clinical practice. The aim of this randomised controlled trial (RCT) is to evaluate the benefits and risks of early versus late PN in term and late preterm infants.

Use of parenteral nutrition in term and late preterm infants: an Australian and New Zealand survey.

There is limited information regarding the use of parenteral nutrition (PN) in term and late preterm infants. We conducted a survey to study the current clinical practices within Australia and New Zealand (ANZ). A fifteen-question online survey was distributed to 232 neonatologists and fifty-five paediatric intensivists across ANZ between September and November 2019.

Early or delayed parenteral nutrition for infants: what evidence is available?

Purpose Of Review: To review the current evidence evaluating early versus delayed commencement of parenteral nutrition in infants.

Recent Findings: Recent studies in very premature infants (<32 weeks gestation) have shown that early commencement of parenteral nutrition immediately after birth improves physical growth. However, there are concerns that early use of very high dose of amino-acids (>3.

Early versus late parenteral nutrition for critically ill term and late preterm infants.

Background: Recently conducted randomised controlled trials (RCTs) suggest that late commencement of parenteral nutrition (PN) may have clinical benefits in critically ill adults and children. However, there is currently limited evidence regarding the optimal timing of commencement of PN in critically ill term and late preterm infants.

Objectives: To evaluate the benefits and safety of early versus late PN in critically ill term and late preterm infants.

Longchain polyunsaturated fatty acid supplementation in preterm infants.

Background: Controversy exists over whether longchain polyunsaturated fatty acids (LCPUFA) are essential nutrients for preterm infants because they may not be able to synthesise sufficient amounts of LCPUFA to meet the needs of the developing brain and retina.

Objectives: To assess whether supplementation of formula milk with LCPUFA is safe and of benefit to preterm infants. The main areas of interest were the effects of supplementation on the visual function, development and growth of preterm infants.

One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.

Background: Animal studies and trials in older children and adults suggest that a 'one dose per day' regimen of gentamicin is superior to a 'multiple doses per day' regimen.

Objectives: To compare the efficacy and safety of one dose per day compared to multiple doses per day of gentamicin in suspected or proven sepsis in neonates.

Search Methods: Eligible studies were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 8 April 2016), MEDLINE (1966 to 8 April 2016), Embase (1980 to 8 April 2016), and CINAHL (December 1982 to 8 April 2016).